Sign in
4

Changes in Ownership

PALISADE BIO, INC. Filed Acc 0001493152-23-003989

Options or other derivatives

  • CEO, CFO, Director acquired 131,400 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Finley John David CEO, CFO, Director 2023-02-06 Grant or award · Restricted Stock Units +41,700 41,700 D
Finley John David CEO, CFO, Director 2023-02-06 Grant or award · Restricted Performance Stock Units +32,500 32,500 D
Finley John David CEO, CFO, Director 2023-02-06 Grant or award · Common Stock Purchase Option +57,200 57,200 D
Loading xslF345X03/ownership.xml…